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Many general practitioners would suspect from their 
every day practice that musculoskeletal conditions 
such as osteoarthritis, rheumatoid arthritis and 
osteoporosis are common general practice clinical 
problems. This has been confirmed by research 
– an estimated 16.7/100 GP-patient encounters are 
for a musculoskeletal condition.1 The costs to the 
community of these conditions are high, both 
economically and because they are a significant 
cause of morbidity and mortality.2,3 Due to the high 
impact of musculoskeletal disorders, the World Health 
Organisation designated 2001–2010 as the ‘bone and 
joint decade’ and, since 2002, arthritis and related 
conditions have been an Australian National Health 
Priority Area.4
The Cochrane Collaboration
The Cochrane Collaboration is an international not-for-profit 
organisation that provides up-to-date information about the 
effects of health care by synthesising the best available 
evidence into systematic reviews.5 The collaboration 
includes a number of Cochrane review groups. The 
Cochrane Musculoskeletal Group (CMSG), established 
in 1993, has become one of the largest Cochrane review 
groups, with over 200 active researchers, health care 
professionals, and consumer representatives from 26 
countries.6 Its main focus is to synthesise the results of 
high quality studies to determine the effectiveness and 
safety of interventions for the prevention, treatment and 
rehabilitation of musculoskeletal disorders. 
 In 2005, an Australian satellite editorial office of the 
CMSG was established, based at Cabrini Hospital in 
Melbourne, Victoria. An important aim of the Australian 
CMSG is to facilitate the dissemination of the results of 
relevant Cochrane reviews to clinicians, consumers, and 
policy makers in Australia. 
Calcium supplements for children
Overview 
Because the use of complementary medicine and 
supplements in the community is high,7 GPs are 
increasingly asked to comment on the usefulness or 
otherwise of these types of interventions. 
 The increasing prevalence of osteoporosis and 
associated fractures2 means that prevention of 
osteoporosis is of great public health importance. 
About 90% of the peak bone mass reached in adult life 
accumulates in childhood,8 so there is increasing interest in 
determining whether intervening in childhood can improve 
peak bone mass.9 Calcium intake plays an important role 
in bone health9 and adequate calcium intakes are widely 
promoted. In view of this, we performed a systematic 
review to answer the question: are calcium supplements 
useful as an intervention to improve bone density in 
healthy children? The review results are given in Table 1 
and how these results might affect practice are shown in 
the case discussions in Table 2.
Conclusion
While it is clear that calcium supplementation in healthy 
children has minimal effect, the review’s results cannot 
be extrapolated to other populations, such as children 
with diseases or who are on medication affecting bone 
metabolism, or those who have a very low calcium intake 
as might be seen in children who completely avoid dairy 
products. Case-by-case assessment will be needed to 
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make decisions about the usefulness of calcium 
supplements for these children until more 
evidence to support practice becomes available 
in these populations.
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Table 1. Key review results10,11
•	 	The	review	included	19	randomised	controlled	trials	(RCTs)	involving	2859	children.	
RCTs	were	in	children	aged	3–18	years,	and	ranged	in	duration	from	8.5	months	to	
7	years	(15	trials	were	1–2	years	long)	
•	 	Calcium	supplementation	does	not	improve	bone	mineral	density	(BMD)	at	two		
of	the	major	sites	of	osteoporotic	fracture	in	later	life:	the	femoral	neck	and		
lumbar	spine	
•	 	A	short	term	increase	in	total	body	bone	mineral	content	was	noted	but	did	not	
persist	after	supplementation	ceased,	so	this	is	unlikely	to	be	clinically	significant	
•	 	There	was	an	increase	in	BMD	at	the	upper	limb,	which	persisted	after	supplements	
were	withdrawn	but	which	was	very	small,	equivalent	to	about	a	1.7%	difference.	
This	is	unlikely	to	produce	a	meaningful	decrease	in	fracture	risk	either	in	childhood	
or	in	adult	life	
•	 	These	results	were	consistent	across	a	range	of	baseline	calcium	intakes	(as	low	as	
300	mg/day)	regardless	of	age	or	gender	
•	 	Adverse	events	were	reported	infrequently	and	were	minor	in	nature,	including	
raised	urinary	calcium	to	creatinine	ratio	(one	child),	and	gastrointestinal	side	
effects	(four	children)	
Table 2. Putting evidence into practice 
Case study 1 
In	the	course	of	a	consultation,	Mrs	Hueso	mentions	that	her	75	year	old	mother	
has	just	fractured	her	hip	in	a	minor	fall.	She	wants	to	discuss	her	own	risk	of	
osteoporosis	with	you	and	also	says:	‘It	makes	me	wonder	about	the	kids,	too.	
Do	you	think	I	should	try	to	get	Julie	(her	15	year	old	daughter)	to	take	calcium	
tablets?’	You	know	Julie	is	a	very	healthy	teenager,	and	ascertain	from	Mrs	Hueso	
that	she	probably	takes	two	serves	of	dairy	products	per	day	on	average.
What can you advise based upon the evidence from the review?
You	can	tell	Mrs	Hueso	that	–	as	Julie	is	healthy	overall	and	as	she	does	consume	
dairy	products	–	adding	a	calcium	supplement	to	her	diet	is	not	worthwhile.	
Calcium	supplements	would	generally	only	be	indicated	in	healthy	children	who	
avoid	dairy	products.
Case study 2 
Mrs	Yeoh	comes	in	with	her	8	year	old	son,	Robert,	whom	you	are	reviewing	a	
week	after	he	presented	with	a	flare	up	of	his	juvenile	idiopathic	arthritis.	You	note	
that	he	has	required	high	doses	of	oral	corticosteroids	over	a	lengthy	period	of	
time.	You	ask	about	Robert’s	diet	and	find	that	he	consumes	a	couple	of	serves	of	
dairy	products	most	days.
Do you suggest that Mrs Yeoh consider giving Robert a calcium supplement?
Robert	is	at	risk	of	low	bone	mineral	density	due	to	his	corticosteroid	use	and	the	
juvenile	arthritis	itself.12,13	While	the	effects	of	calcium	supplementation	in	healthy	
children	are	small,	the	studies	in	the	review	excluded	children	with	other	medical	
conditions	which	might	affect	bone	health.	Therefore	these	results	may	not	apply	
to	Robert.	Unfortunately	there	are	no	published	RCTs	in	children	that	address	
Robert’s	situation.	The	review	did	show	that	the	side	effects	of	using	calcium	
supplements	were	minor	and	infrequent,	so	taking	calcium	supplements	is	unlikely	
to	cause	harm	and	may	provide	benefits	(based	on	extrapolation	from	trials	in	
adults).	You	decide	to	discuss	the	evidence	with	Mrs	Yeoh	and	Robert	and	present	
calcium	supplementation	as	an	option. CORRESPONDENCE email: afp@racgp.org.au
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